34 /100
MEDIUM RISK
Score updated Jul 14, 2026

ZYBT — Zhengye Biotechnology Holding Limited Dilution Risk Tracker

Track ZYBT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ZYBT — Get alerts when the score changes →

As of July 14, 2026, Zhengye Biotechnology Holding Limited (ZYBT) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. Zhengye Biotechnology Holding Limited has a market capitalization of $40.29M, 47.39M shares outstanding, 8 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
77
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.93 below $1 exchange minimum
🔔 Track ZYBT — Get forecast alerts →

💹 Market Data

Market Cap$40.29M
Shares Outstanding47.39M
Float6.26M
Cash$2.77M
Debt$758.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 46.0% shares (2026Q1 vs prior)
8 institutional holders · 124.7K shares
#1 XTX Topco Ltd 44.1K shares
#2 WINTON GROUP Ltd 33.4K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 29.1K shares
+ 5 more holders Sign up free to view →

📉 Short Interest

Short Interest43.5K
Days to Cover2.1
% of Float0.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for ZYBT Shareholders

Zhengye Biotechnology Holding Limited (ZYBT) has a DilutionScore of 34/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for ZYBT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ZYBT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ZYBT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ZYBT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ZYBT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ZYBT
📊 ZYBT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ZYBT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.